Combined hepatic arterial embolization and hepatic ablation for unresectable colorectal metastases to the liver

American Surgeon

Volumn 78, Issue 11, 2012, Pages 1243-1248

  Fong, Zhi Ven ^a   Palazzo, Francesco ^a   Needleman, Laurence ^a   Brown, Daniel B ^a   Eschelman, David J ^a   Chojnacki, Karen A ^a   Yeo, Charles J ^a   Rosato, Ernest L ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; FENOFIBRATE; GELFOAM; MITOMYCIN; YTTRIUM 90;

ADULT; AGED; ARTICLE; CANCER INVASION; CAVA VEIN; CHEMOEMBOLIZATION; CHOLECYSTITIS; CLINICAL ARTICLE; COLORECTAL CANCER; CRYOABLATION; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LENGTH OF STAY; LIVER ABSCESS; LIVER METASTASIS; LIVER VEIN; LIVER VEIN THROMBOSIS; LONG TERM SURVIVAL; MALE; MICROWAVE THERAPY; OVERALL SURVIVAL; PNEUMOTHORAX; PORTAL VEIN; PORTAL VEIN THROMBOSIS; POSTOPERATIVE ILEUS; RADIOFREQUENCY ABLATION; TUMOR ABLATION; TUMOR VOLUME;

ADENOCARCINOMA; AGED; CATHETER ABLATION; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; RETROSPECTIVE STUDIES;

EID: 84867913238     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Steele G Jr, Ravikumar TS. Resection of hepatic metastases from colorectal cancer. Biologic Perspective. Ann Surg 1989;210: 127-38. (Pubitemid 19188702)
2. Minagawa M, Makucchi M, Torzilli G, et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long term results. Ann Surg 2000;231:487-99. (Pubitemid 30185854)
3. de Haas RJ, Wicherts DA, Salloum C, et al. Long-term outcomes after hepatic resection for colorectal metastases in young patients. Cancer 2010;116:647-58.
4. Morris EJ, Forman D, Thomas JD, et al. Surgical management and outcomes of colorectal cancer liver metastases. Br J Surg 2010;97:1110-1.
5. Isoniemi H, Osterlund P. Surgery combined with oncological treatments in liver metastases from colorectal cancer. Scand J Surg 2011;100:35-41.
6. Wagner JS, Adson MA, Heerden JA. The natural history of hepatic metastases fromcolorectal cancer. Ann Surg 1984;199:502-8.
7. Saltz LB, Cox JV, Blanke C, et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 2000;343:905-14.
8. Heinemann V, Hoff PM. Bevacizumab plus irinotecan-based regimens in the treatment of metastatic colorectal cancer. Oncology 2010;79:118-28.
9. Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004;350:2335-42. (Pubitemid 38702844)
10. Lo CM, Ngan H, Tso WK, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002;35:1164-71. (Pubitemid 34454013)
11. Llovet JM, Real MI, Montaña X, et al.; Barcelona Liver Cancer Group. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002;359: 1734-9. (Pubitemid 34607087)
12. Albert M, Kiefer MV, Sun W, et al. Chemoembolization of colorectal liver metastases with cisplatin, doxorubicin, mitomycin C, Ethiodol, and polyvinyl alcohol. Cancer 2011;117:343-52.
13. Stuart JE, Tan B, Myerson RJ, et al. Salvage radioembolization of liver-dominant metastases with a resin-based microsphere: initial outcomes. J Vasc Interv Radiol 2008;19: 1427-33.
14. Jakobs TF, Hoffmann RT, Dehm K, et al. Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases. J Vasc Interv Radiol 2008;19:1187-95.
15. Berber E, Pelley R, Sisperstein AE. Predictors of survival after radiofrequency thermal ablation of colorectal cancer metastasis to the liver: a prospective study. J Clin Oncol 2005;23: 1358-64.
16. Martin RC, Scoggins CR, McMasters KM. Safety and efficacy of microwave ablation of hepatic tumors: a prospective review of a 5-year experience. Ann Surg Oncol 2010;17:171-8.
17. Ruers TJ, Joosten J, Jager GJ, et al. Long-term results of treating hepatic colorectal metastases with cryosurgery. Br J Surg 2001;88:844-9. (Pubitemid 32823838)
18. Salem R, Lewandowski RJ, Gates VL, et al.; Technology Assessment Committee. Interventional Oncology Task Force of the Society of Interventional Radiology. Research reporting standards for radioembolization of hepatic malignancies. J Vasc Interv Radiol 2011;22:265-78.
19. Brown DB, Gould JE, Gervais DA, et al.; Society of Interventional Radiology Technology Assessment Committee and the International Working Group on Image-Guided Tumor Ablation. Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. J Vasc Interv Radiol 2009; 20(suppl):S425-34.
20. Mann CD, Metcalfe MS, Lloyd DM, et al. The safety and efficacy of ablative techniques adjacent to the hepatic vasculature and biliary system. ANZ J Surg 2010;80:41-9.
21. Lu DS, Raman SS, Vodopich DJ, et al. Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: assessment of the 'heat sink' effect. AJR Am J Roentgenol 2002;178:47-51. (Pubitemid 34016368)
22. Lu DS, Raman SS, Limanond P, et al. Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. J Vasc Interv Radiol 2003;14:1267-74. (Pubitemid 37266660)
23. Patterson EJ, Scudamore CH, Owen DA, et al. Radiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size. Ann Surg 1998;227:559-65. (Pubitemid 28363274)
24. Hur H, Ko YT, Min BS, et al. Comparative study of resection and radiofrequency ablation in the treatment of solitary colorectal liver metastases. Am J Surg 2009;197:728-36.
25. Berber E, Siperstein AE. Perioperative outcome after laparoscopic radiofrequency ablation of liver tumors: an analysis of 521 cases. Surg Endosc 2007;21:613-8. (Pubitemid 46439380)
26. Curley SA, Izzo F, Delrio P, et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 1999;230:1-8. (Pubitemid 30190357)
27. Gnerlich JL, Ritter JH, Linehan DC, et al. Saline-linked surface radiofrequency ablation: a safe and effective method of surface ablation of hepatic colorectal cancer. Ann Surg 2009;250: 96-102.
28. Solbiati L, Livraghi T, Goldberg SN, et al. Percutaneous radiofrequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 2001;221:159-66. (Pubitemid 32880383)
29. Oshowo A, Gillams A, Harrison E, et al. Comparison of resection and radiofrequency ablation for solitary colorectal liver metastases. Br J Surg 2003;90:1240-3. (Pubitemid 37330428)
30. Tanaka K, Shimada H, Nagano Y, et al. Outcome after hepatic resection versus combined resection and microwave ablation for multiple bilobar colorectal metastases to the liver. Surgery 2006;139:263-73. (Pubitemid 43170328)
31. Xu KC, Niu LZ, HeWB, et al. Percutaneous cryosurgery for the treatment of hepatic colorectalmetastases.World J Gastroenterol 2008;14:1430-6.
32. Seifert JK, Junginger T, Morris DL. A collective review of the world literature on hepatic cryotherapy. J R Coll Surg Edinb 1998;43:141-54. (Pubitemid 28306028)
33. Kulaylat MN, Gibbs JF. Thermoablation of colorectal liver metastasis. J Surg Oncol 2010;101:699-705.
34. Ahmed M, Brace CL, Lee FT Jr, et al. Principles of and advances in percutaneous ablation. Radiology 2011;258:351-69.
35. Haemmerich D, Wood BJ. Hepatic radiofrequency ablation at low frequencies preferentially heats tumour tissue. Int J Hyperthermia 2006;22:563-74. (Pubitemid 44669662)
36. Brace CL. Microwave ablation technology: what every user should know. Curr Probl Diagn Radiol 2009;38:61-7.
37. Chinn SB, Lee FT Jr, Kennedy GD, et al. Effect of vascular occlusion on radiofrequency ablation of the liver: results in a porcine model. AJR Am J Roentgenol 2001;176:789-95. (Pubitemid 32181988)
38. Tellez C, Benson AB III, Lyster MT, et al. Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature. Cancer 1998;82: 1250-9. (Pubitemid 28155386)
39. 90Y- microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience. Int J Radiat Oncol Biol Phys 2006;65:412-25.
40. Maataoui A, Qian J, Mack MG, et al. Liver metastases in rats: chemoembolization combined with interstitial laser ablation for treatment. Radiology 2005;237:381-2.
41. Rossi S, Garbagnati F, Lencioni R, et al. Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology 2000; 217:119-26. (Pubitemid 33097587)
42. Lencioni R, Crocetti L, Petruzzi P, et al. Doxorubicin-eluting bead-enhanced radiofrequency ablation of hepatocellular carcinoma: a pilot clinical study. J Hepatol 2008;49:217-22.